Aspirin and Dipyridamole

FDA Drug Profile — Aspirin and Dipyridamole

Drug Details

Generic Name
Aspirin and Dipyridamole
Brand Names
Aspirin and Dipyridamole
Application Number
ANDA209048
Sponsor
Dr. Reddy's Laboratories Inc
NDC Codes
2
Dosage Forms
CAPSULE, EXTENDED RELEASE
Routes
ORAL
Active Ingredients
ASPIRIN, DIPYRIDAMOLE

Indications and Usage

1 INDICATIONS AND USAGE Aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. Aspirin and extended-release dipyridamole capsules are a combination of aspirin and dipyridamole, antiplatelet agents, indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis ( 1 )